Q Laboratories Blog Compounding Pharma Guidance

In January, the FDA released the second revision of the Draft Guidance, "Current Good Manufacturing Practice-Guidance for Human Drug Compounding Outsourcing Facilities Under Section 503B of the FD&C Act." The Agency initially submitted the Draft Guidance in 2014 and followed up with Revision One in December 2018. Currently, GMPs for drug ... Read moreThe post Compounding Pharma Guidance appeared first on Welcome to Q Laboratories.